Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Galectin-levels are elevated in infants born preterm due to amniotic infection and rapidly decline in the neonatal period

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
741kB
[thumbnail of Supplementary Material] Other (Supplementary Material)
80kB

Item Type:Article
Title:Galectin-levels are elevated in infants born preterm due to amniotic infection and rapidly decline in the neonatal period
Creators Name:Faust, K., Freitag, N., Barrientos, G., Hartel, C. and Blois, S.M.
Abstract:Galectin (gal)-1, -3, and -9 are members of a family of glycan binding proteins that mediate complex interactions between decidual, inflammatory and trophoblast cells modulating several processes during gestation, control of the maternal immune system, and parturition. Their immunomodulatory role in preterm birth and postnatal expression in preterm infants is unknown. We performed a single center prospective study of 170 preterm infants with a gestational age below 35 weeks. Peripheral venous blood samples were collected during the neonatal period and galectin-1, -3, and -9 were determined by ELISA. We noted a strong decline of circulating gal-1 and -3 levels but not gal-9 from birth to day 7 of life. There was an inverse correlation of gal-1 and -3 levels at birth with gestational age. Gal-1 levels were remarkably increased in infants born to amniotic infection syndrome (AIS), which was also observed for gal-9 levels. Infants who developed early-onset sepsis had higher levels of gal-3 at day 1 as compared to unaffected infants. Our observational data imply that galectin-1, -3, and -9 levels are elevated in preterm infants born in an inflammatory milieu such as AIS or EOS. Future studies need to address whether galectins mediate inflammation-induced preterm birth and could therefore be a target for clinical trials.
Keywords:Galectin-1, Galectin-3, Galectin-9, Preterm Infants, Amniotic Infection
Source:Frontiers in Immunology
ISSN:1664-3224
Publisher:Frontiers Media SA
Volume:11
Page Range:599104
Date:25 February 2021
Official Publication:https://doi.org/10.3389/fimmu.2020.599104
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library